Sign In
Buy STIM
$1.20
-0.0300 (-2.44%)
At Close: Jun 22, 2026
Neuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
04:05pm, Monday, 30'th Nov 2020
MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
Neuronetics iTBS: Quick Electromagnetic Stimulation For Depression
07:29am, Thursday, 26'th Nov 2020
Neuronetics makes a device that stimulates the brain, showing efficacy in MDD patients. Despite being in business for nearly two decades, this is a small company and a depressed stock.
Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol
04:05pm, Monday, 23'rd Nov 2020
TouchStar theta burst protocol leverages NeuroStar® Advanced Therapy's patented Contact Sensing technology to help ensure the optimum prescribed treatment dose to patients TouchStar theta burst proto
Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum
04:05pm, Thursday, 12'th Nov 2020
MALVERN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve th
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q3 2020 Results - Earnings Call Transcript
05:19am, Tuesday, 03'rd Nov 2020
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q3 2020 Results - Earnings Call Transcript
Neuronetics (STIM) Reports Q3 Loss, Tops Revenue Estimates
06:15pm, Monday, 02'nd Nov 2020
Neuronetics (STIM) delivered earnings and revenue surprises of 41.94% and 11.44%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Neuronetics Reports Third Quarter 2020 Financial and Operating Results
04:05pm, Monday, 02'nd Nov 2020
MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the
